A major discovery in cancer research is emerging with the use of mini-antibodies to reactivate dysfunctional p53. This essential tumor suppressor protein is frequently disabled in many forms of cancer, causing https://growthbookmarks.com/story21910264/nanobodies-revive-tumor-suppressor-p53-a-potential-pathway-for-cancer-treatment